Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

4.25
-0.1900-4.28%
Volume:708.28K
Turnover:3.02M
Market Cap:393.85M
PE:-9.19
High:4.55
Open:4.44
Low:4.16
Close:4.44
52wk High:13.99
52wk Low:2.86
Shares:92.67M
Float Shares:83.05M
Volume Ratio:0.45
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4626
EPS(LYR):-0.5438
ROE:-33.63%
ROA:-21.56%
PB:3.11
PE(LYR):-7.82

Loading ...

Anavex trading halted, volatility trading pause

TIPRANKS
·
Nov 14, 2025

Anavex Seeks Re-examination of Blarcamesine After CHMP Feedback

Reuters
·
Nov 14, 2025

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

THOMSON REUTERS
·
Nov 14, 2025

Anavex Life Sciences Corp - Chmp Informs Anavex of Negative Trend Vote on Maa for Blarcamesine

THOMSON REUTERS
·
Nov 14, 2025

Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX) and Anavex Life Sciences (AVXL)

TIPRANKS
·
Oct 29, 2025

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 29, 2025

Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group

Benzinga_recent_news
·
Oct 29, 2025

Anavex Life Sciences Corp - Blarcamesine Shows Favorable Safety Profile With No Treatment-Related Deaths

THOMSON REUTERS
·
Oct 29, 2025

Anavex Life Sciences Corp - Blarcamesine Confirmed to Restore Impaired Autophagy

THOMSON REUTERS
·
Oct 29, 2025

Anavex Life Sciences Announces Continued Long-Term Benefit From Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (Adni) Control Group

THOMSON REUTERS
·
Oct 29, 2025

Anavex Life Sciences Corp - 77.4 Weeks 'Time Saved' With Blarcamesine Compared to Adni

THOMSON REUTERS
·
Oct 29, 2025

Anavex Life Sciences Cut to Hold From Buy by Jones Trading

Dow Jones
·
Oct 24, 2025

U.S. RESEARCH ROUNDUP-Blackstone, Ford, Intel

Reuters
·
Oct 24, 2025

Anavex Life Sciences Corp : Jonestrading Cuts to Hold Rating

THOMSON REUTERS
·
Oct 24, 2025

JonesTrading Reaffirms Their Hold Rating on Anavex Life Sciences (AVXL)

TIPRANKS
·
Oct 24, 2025

US High Growth Tech Stocks To Watch For Potential Expansion

Simply Wall St.
·
Oct 17, 2025

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

GlobeNewswire
·
Oct 10, 2025

Anavex Life Sciences Price Target Maintained With a $42.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 07, 2025

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires Live
·
Oct 03, 2025

BUZZ-Anavex rises after schizophrenia drug meets main goal in study

Reuters
·
Oct 02, 2025